申请人:Storck Pierre Henri
公开号:US20130005769A1
公开(公告)日:2013-01-03
The present invention provides compounds of formula (I), their use as an inhibitor of a p53-MDM2 interaction as well as pharmaceutical compositions comprising said compounds:
wherein n, s, t, R
1
, R
2
, R
3
, R
4
, R
5
, X, Y, Q, Z, G, E and D have defined meanings.